Homocysteine: new tumor marker in pleural fluid
- 9 May 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (10) , 7941-7945
Abstract
There are no published studies examining the utility of total homocysteine (HCY) in pleural fluid. The aim was to measure the accuracy of pleural fluid HCY concentration for diagnosis of malignant pleural effusion (MPE). We studied pleural fluids obtained by thoracocentesis in patients with pleural effusion. Pleural fluid HCY concentration was measured by immunonephelometry using N Latex HCY reagent with monoclonal antibody in automated analyzers BNII (Siemens Diagnostics®). Patients were classified into two groups according to the etiology of pleural effusion: benign pleural effusions (BPE) and MPE. Pleural effusion was categorized as MPE if malignant cells were demonstrated in pleural fluid or pleural biopsy. The accuracy of pleural fluid HCY concentration for diagnosis of MPE was determined using receiver operating characteristic (ROC) techniques by analyzing the area under the ROC curve (AUC). We studied 89 patients with ages between 1 and 96 years old (median = 66). Forty-eight patients were BPE and 41 were MPE. Pleural fluid HCY concentration was significantly higher in patients with MPE (median = 13.70 μmol/L) than in those with BPE (median = 8.05 μmol/L). The AUC value was 0.833 (95 % confidence interval (CI) 0.739–0.903). The optimal cutoff value was 13.1 μmol/L exhibiting 56.1 % (95 % CI 39.8–71.5) sensitivity and 85.4 % (95 % CI 72.2–93.9) specificity. Pleural fluid HCY concentration showed high diagnostic accuracy to predict whether a pleural effusion is benign or malignant. Pleural fluid HCY concentration may be measured easily and quickly in automated analyzers and could be a tumor marker commonly used for diagnosis of MPE.Keywords
This publication has 30 references indexed in Scilit:
- Malignant Pleural EffusionsClinics in Chest Medicine, 2013
- The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancerClinica Chimica Acta, 2013
- Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: Cross‐sectional and prospective studies and meta‐analyses of 75,000 cases and 93,000 controlsInternational Journal of Cancer, 2010
- Rendimiento diagnóstico de la determinación del antígeno carcinoembrionario en el líquido pleuralMedicina Clinica, 2010
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010Thorax, 2010
- Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: A meta‐analysisRespirology, 2008
- Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysisThorax, 2008
- Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine studyAnnals of Neurology, 2005
- Clinical Evaluation of the Simultaneous Determination of Tumor Markers in Fluid and Serum and Their Ratio in the Differential Diagnosis of Serous EffusionsTumor Biology, 2004
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995